AGIO

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AGIO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	23:00	GlobeNewswire Inc.	Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/05/06	20:00	GlobeNewswire Inc.	Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/05/03	20:00	GlobeNewswire Inc.	Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/05/02	20:00	GlobeNewswire Inc.	Agios Reports Business Highlights and First Quarter 2024 Financial Results	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/04/18	20:00	GlobeNewswire Inc.	Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/04/09	20:00	GlobeNewswire Inc.	Agios Publishes 2024 Environmental, Social and Governance (ESG) Report	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/08	08:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/05	21:00	GlobeNewswire Inc.	Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/01	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/28	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/27	11:21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/23	07:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/22	21:00	GlobeNewswire Inc.	Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/16	00:33	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	21:00	GlobeNewswire Inc.	Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	07:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	07:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	07:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	04:21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	04:06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AGIO	Agios Pharmaceuticals Inc